Article Title: Potential of BGB-11417, a BCL2 inhibitor, in hematological malignancies
Authors: Bruzzese, A., Martino, E.A., Labanca, C., Mendicino, F., Lucia, E., Olivito, V., Neri, A., Morabito, F., Vigna, E., & Gentile M.
Journal: Expert Opinion on Investigational Drugs
DOI: http://dx.doi.org/10.1080/13543784.2024.2309873
The article title was published online with the incorrect drug name “BGB-1417” instead of “BGB-11417”. Now, it has been replaced with the below article title in the original version.
Potential of BGB-11417, a BCL2 inhibitor, in hematological malignancies